Exercise Habits in Patients With Ankylosing Spondylitis Before and After the Introduction of Biological Therapy

Authors

  • Ljiljana Ilić Faculty of Medicine University of Novi Sad Author

Keywords:

ankylosing spondylitis, biological therapy, physical activity, quality of life

Abstract

Introduction: Ankylosing spondylitis (AS) is a chronic inflammatory disease that may cause functional limitations. Physical activity is an important part of non-pharmacological treatment.

Aim: To investigate exercise habits in patients with AS before and after the introduction of biological therapy, and the association of physical activity with disease activity, functional status and quality of life.

Materials and Methods: This prospective study included 40 patients with AS treated at the Special Hospital for Rheumatic Diseases in Novi Sad. Baseline BASDAI and BASFI scores were obtained from medical records. Physical activity was assessed using the IPAQ, and quality of life using the ASQoL questionnaire. The mean duration of biological therapy was 5.13 ± 3.65 years.

Results: The proportion of patients exercising several times a week increased from 25% before to 35% after the introduction of therapy, while the proportion of patients who did not exercise decreased from 30% to 20%. Moderate physical activity was reported by 70% of participants. The mean ASQoL score was 4.73 ± 5.22. Differences in BASDAI and BASFI scores between physical activity groups were not statistically significant (p=0.811; p=0.131). BASFI was positively correlated with ASQoL (r=0.325; p=0.041), whereas the BASDAI–ASQoL correlation was not statistically significant (r=0.277; p=0.083).

Conclusion: Exercise frequency increased after the introduction of biological therapy. Although no statistically significant association was found between physical activity and disease activity or functional status, poorer functional status was associated with poorer quality of life. These findings highlight the importance of preserving functional ability and independence in patients with AS.

Published

2026-11-18

Issue

Section

Abstracts